Midatech Pharma PLC Stock News

THIS ANNOUNCEMENT IS NOT AN OFFER TO SELL OR A SOLICITATION TO BUY SECURITIES IN ANY JURISDICTION, INCLUDING THE UNITED STATES, CANADA, AUSTRALIA, JAPAN AND THE REPUBLIC OF SOUTH AFRICA. Upon the clo

ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 18, 2020 / Midatech Pharma PLC ("Midatech" or the "Company") (AIM:MTPH.L; NASDAQ:MTP), an R&D; biotechnology company focused on delivering innovative oncology

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). With the publi

LONDON, UK / ACCESSWIRE / May 12, 2020 / Midatech Pharma PLC (AIM:MTPH.L)(MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines announces tha

ABINGDON, OXFORDSHIRE / ACCESSWIRE / May 1, 2020 / Midatech Pharma PLC (MTPH.L)(MTP), a drug delivery technology company focused on improving the bio-delivery and bio-distribution of medicines notes t

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 22, 2020 / Midatech Pharma PLC (MTP)(MTPH.L) The following amendment has been made to Midatech's 2.9 announcement that was released on the 20 April 2020 whic

ABINGDON, OXFORDSHIRE / ACCESSWIRE / April 20, 2020 / In accordance with Rule 2.9 of the Takeover Code, Midatech confirms that, as at the date of this announcement, it has 23,494,981 ordinary shares w

THIS IS AN ANNOUNCEMENT UNDER RULE 2.4 OF THE CITY CODE ON TAKEOVERS AND MERGERS (THE "TAKEOVER CODE") AND IS NOT AN ANNOUNCEMENT OF A FIRM INTENTION TO MAKE AN OFFER UNDER RULE 2.7 OF THE TAKEOVER CO

LONDON / ACCESSWIRE / March 31, 2020 / Midatech Pharma PLC (MTPH.L)(MTP), an R&D; biotechnology company focused on delivering innovative oncology and rare disease products to patients announces that,

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 3) Acceleron Pharma Inc (NASDAQ: XLRN ) BioMarin Phar

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 2, 2020 / Midatech Pharma PLC (AIM:MTPH.L; NASDAQ:MTP) ("Midatech" or the "Company"), an R&D; biotechnology company focused on delivering innovative oncology

ABINGDON, OXFORDSHIRE / ACCESSWIRE / March 2, 2020 / Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), an R&D; biotechnology company focused on delivering innovative oncology and rare disease products t

Midatech Pharma announces posting of Circular convening a General Meeting Share Consolidation and ADR Ratio Change ABINGDON, OXFORDSHIRE / ACCESSWIRE / February 12, 2020 / Midatech Pharma PLC (AIM:MTP

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Jan. 7) Apellis Pharmaceuticals Inc (NASDAQ: APLS ) (announ

ABINGDON, OXFORDSHIRE / ACCESSWIRE / January 8, 2020 / Midatech Pharma PLC (AIM: MTPH.L; Nasdaq: MTP), an R&D; biotechnology company focused on delivering innovative oncology and rare disease products